Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates the use of alemtuzumab in combination chemotherapy for newly diagnosed stage II, stage III, or stage IV T-cell non-Hodgkin lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: Toronto Sunnybrook Regional Cancer Centre | Conditions: Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN